Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Idarucizumab, a Specific Antidote for Dabigatran, Cross-Reacts with Melagatran and May Also Interact with Other Benzamidine-Containing Compounds

Jawed Fareed, PhD, Larissa Reikensmeyer, Amanda Walborn, BS, Debra Hoppensteadt, PhD, Jeanine M. Walenga, PhD, Eduardo Ramacciotti, MD, Schuharazad Abro, MD, Walter Jeske, PhD, Olivia Bouchard, Ismail Elalamy, MD PhD

Blood (2016) 128 (22): 3836.

https://doi.org/10.1182/blood.V128.22.3836.3836

Published: 2016

Journal Articles

Relieving Inhibition of Prothrombinase By TFPIα: a Procoagulant Activity of Unfractionated, Low Molecular Weight, and Nonanticoagulant Heparins

Jeremy P Wood, PhD, Lisa M Baumann Kreuziger, MD, Rodney M. Camire, PhD, Umesh R Desai, PhD, Alan E. Mast, MD PhD

Blood (2014) 124 (21): 1478.

https://doi.org/10.1182/blood.V124.21.1478.1478

Published: 2014

Journal Articles

Alpha-2-Macroglobulin Is a Major Determinant Of a Lower Thrombin Generation In Infants and Children Compared To Adults

Romy Kremers, Saartje Bloemen, Raed Al Dieri, PhD, Coen H Hemker, Vasiliki Karlaftis, Chantal Attard, Bas de Laat, PhD, Paul Monagle, MBBS, MD, MSc, Vera Ignjatovic, PhD

Blood (2013) 122 (21): 2344.

https://doi.org/10.1182/blood.V122.21.2344.2344

Published: 2013

Journal Articles

Anticoagulant Activity and Mechanism of Non-Anticoagulant Sulfated Polysaccharides

Michael Dockal, PhD, Susanne Till, PhD, Sabine Knappe, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD

Blood (2011) 118 (21): 1208.

https://doi.org/10.1182/blood.V118.21.1208.1208

Published: 2011

Journal Articles

Comparative Studies on An Anti-Xa Enriched Ultra Low Molecular Weight Heparin with Bemiparin

Debra Hoppensteadt, Ph.D., Angel Gray, Josephine Cunanan, MD, Walter Jeske, Ph.D., Jeanine M. Walenga, PhD, Jawed Fareed, PhD

Blood (2010) 116 (21): 4394.

https://doi.org/10.1182/blood.V116.21.4394.4394

Published: 2010

Journal Articles

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

Jawed Fareed, Melanie Clark, Vinod Bansal, Lauren Myers, Omer Iqbal, MD, Debra Hoppensteadt, Eduardo Ramacciotti, M.D., Ph.D., Jeanine M. Walenga, PhD

Blood (2009) 114 (22): 1069.

https://doi.org/10.1182/blood.V114.22.1069.1069

Published: 2009

Journal Articles

Oversulfated Chondroitin Sulfate Is Not the Sole Contaminant in Recalled Heparin Preparations.

Jawed Fareed, Eduardo Ramacciotti, Debra Hoppensteadt, Nasir Sadeghi, Arif Hussain, David VanThiel, Magdalena George

Blood (2009) 114 (22): 1070.

https://doi.org/10.1182/blood.V114.22.1070.1070

Published: 2009

Journal Articles

Genetic Risk Factors of Thrombosis.

Pieter H. Reitsma, PhD

Blood (2009) 114 (22): SCI-43.

https://doi.org/10.1182/blood.V114.22.SCI-43.SCI-43

Published: 2009

Journal Articles

Depolymerized Holothurian Glycosaminoglycan Inhibits Plasma Thrombin Generation Via Interaction with the Factor IXa Heparin-Binding Exosite

Buyue Yang, John P. Sheehan, MD

Blood (2008) 112 (11): 3081.

https://doi.org/10.1182/blood.V112.11.3081.3081

Published: 2008

Journal Articles

Heparin Cofactor II (HCII) Levels and the Risk of Ischemic Stroke. No Deleterious Role of HCII Deficiency but Potential Protective Role of High Plasma Level

Pierre A. Toulon, Mathieu Zuber, Raphael Adda, Jean-Louis Mas

Blood (2008) 112 (11): 5344.

https://doi.org/10.1182/blood.V112.11.5344.5344

Published: 2008

Journal Articles

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II

Li He, Tusar K. Giri, Cristina P. Vicente, Douglas M. Tollefsen

Blood (2008) 111 (8): 4118–4125.

https://doi.org/10.1182/blood-2007-12-127928

Published: 2008

Journal Articles

Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient mice

Cristina P. Vicente, Li He, Douglas M. Tollefsen

Blood (2007) 110 (13): 4261–4267.

https://doi.org/10.1182/blood-2007-04-086611

Published: 2007

Journal Articles

Compositional Differences in the Oligosaccharide Components of Generic Versions of Enoxaparin and Dalteparin.

Walter P. Jeske, PhD, Aleah Brubaker, B.S., Debra Hoppensteadt, Ph.D., Jeanine M. Walenga, Ph.D., Qing Ma, Ph.D., Jawed Fareed, Ph.D.

Blood (2007) 110 (11): 3999.

https://doi.org/10.1182/blood.V110.11.3999.3999

Published: 2007

Journal Articles

Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II

Tusar K. Giri, Douglas M. Tollefsen

Blood (2006) 107 (7): 2753–2758.

https://doi.org/10.1182/blood-2005-09-3755

Published: 2006

Journal Articles

Depolymerized Holothurian Glycosaminoglycan and Heparin Inhibit the Intrinsic Tenase Complex by a Common Antithrombin-Independent Mechanism.

John P. Sheehan, MD, Erik N. Walke

Blood (2005) 106 (11): 1011.

https://doi.org/10.1182/blood.V106.11.1011.1011

Published: 2005

Journal Articles

The Heparin Binding Properties of Heparin Cofactor II Suggest an Antithrombin -Like Activation Mechanism.

Denis J. Okeeffe, MBBCH, Trevor P. Baglin, MD, John T. Gallagher, PhD, Steve T. Olson, PhD, James A. Huntington, PhD

Blood (2004) 104 (11): 1718.

https://doi.org/10.1182/blood.V104.11.1718.1718

Published: 2004

Journal Articles

Role of Thrombin Exosites in Protection from Inhibition by Antithrombin in the Presence of Heparin and Fibrin.

James C. Fredenburgh, PhD, Alan R. Stafford, MSc, Jeffrey I. Weitz, MD

Blood (2004) 104 (11): 1721.

https://doi.org/10.1182/blood.V104.11.1721.1721

Published: 2004

NARROW

Idarucizumab, a Specific Antidote for Dabigatran, Cross-Reacts with Melagatran and May Also Interact with Other Benzamidine-Containing Compounds

Relieving Inhibition of Prothrombinase By TFPIα: a Procoagulant Activity of Unfractionated, Low Molecular Weight, and Nonanticoagulant Heparins

Alpha-2-Macroglobulin Is a Major Determinant Of a Lower Thrombin Generation In Infants and Children Compared To Adults

Anticoagulant Activity and Mechanism of Non-Anticoagulant Sulfated Polysaccharides

Comparative Studies on An Anti-Xa Enriched Ultra Low Molecular Weight Heparin with Bemiparin

Contaminants Isolated From Recalled Heparin Are Not All the Same: Clinical Implications.

Oversulfated Chondroitin Sulfate Is Not the Sole Contaminant in Recalled Heparin Preparations.

Genetic Risk Factors of Thrombosis.

Depolymerized Holothurian Glycosaminoglycan Inhibits Plasma Thrombin Generation Via Interaction with the Factor IXa Heparin-Binding Exosite

Heparin Cofactor II (HCII) Levels and the Risk of Ischemic Stroke. No Deleterious Role of HCII Deficiency but Potential Protective Role of High Plasma Level

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II

Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient mice

Compositional Differences in the Oligosaccharide Components of Generic Versions of Enoxaparin and Dalteparin.

Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II

Depolymerized Holothurian Glycosaminoglycan and Heparin Inhibit the Intrinsic Tenase Complex by a Common Antithrombin-Independent Mechanism.

The Heparin Binding Properties of Heparin Cofactor II Suggest an Antithrombin -Like Activation Mechanism.

Role of Thrombin Exosites in Protection from Inhibition by Antithrombin in the Presence of Heparin and Fibrin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only